Quipt Home Medical Corp. (QIPT) Financials
Newest figures come from the 10-Q for Q1 FY2026, filed Feb 9, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the QIPT SEC filings page.
Quipt Home Medical Corp. (QIPT) reported $265.0M in revenue over the twelve months to Dec 31, 2025, up 8.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue is flat while margins weaken, yet cash generation remains positive because heavy noncash charges support a reinvestment-heavy operating model.
The cash conversion split is notable: FY2025 produced operating cash flow of$37.7M despite a net loss, showing reported earnings understate cash generation in this period. But capex of$12.4M kept free cash flow margin to10.3% , so reinvestment absorbs a material share of operating cash.
The company is not scaling through volume: revenue was effectively flat in FY2025, while gross margin remained
From FY2023 to FY2025, negative equity of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Quipt Home Medical Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Quipt Home Medical Corp. has an operating margin of -1.6%, meaning the company loses $2 on every $100 of revenue. This results in a profitability score of 24/100. This is down from 0.4% the prior year.
Quipt Home Medical Corp.'s revenue declined 0.2% year-over-year, from $245.9M to $245.4M. This contraction results in a growth score of 59/100.
Quipt Home Medical Corp. has a moderate D/E ratio of 0.78. This balance of debt and equity financing earns a leverage score of 34/100.
Quipt Home Medical Corp.'s current ratio of 1.05 is below the typical benchmark, resulting in a score of 21/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Quipt Home Medical Corp. converts 10.3% of revenue into free cash flow ($25.3M). This strong cash generation earns a score of 69/100.
Quipt Home Medical Corp. posts a -9.6% return on equity (ROE), meaning it loses $10 for every $100 of shareholders' equity. This results in a returns score of 23/100. This is down from -6.3% the prior year.
Quipt Home Medical Corp. scores 0.51, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($162.3M) relative to total liabilities ($171.2M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Quipt Home Medical Corp. passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
Quipt Home Medical Corp. reported a net loss of $10.7M while generating $37.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Quipt Home Medical Corp. reported an operating loss of $3.8M against $5.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Quipt Home Medical Corp. generated $81.0M in revenue in Q1 2026. This represents an increase of 32.0% from the same quarter a year earlier. Against the prior quarter it is up 18.6%.
Quipt Home Medical Corp.'s EBITDA was $13.6M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 18.7% from the same quarter a year earlier. Against the prior quarter it is up 37.6%.
Quipt Home Medical Corp. reported -$1.1M in net income in Q1 2026. This represents an increase of 2.9% from the same quarter a year earlier. Against the prior quarter it is up 70.3%.
Quipt Home Medical Corp. earned -$0.02 per diluted share (EPS) in Q1 2026. This represents an increase of 33.3% from the same quarter a year earlier. Against the prior quarter it is up 71.4%.
Cash & Balance Sheet
Quipt Home Medical Corp. generated $6.9M in free cash flow in Q1 2026, representing cash available after capex. This represents an increase of 22.2% from the same quarter a year earlier. Against the prior quarter it is down 13.7%.
Quipt Home Medical Corp. held $10.5M in cash against $84.0M in long-term debt as of Q1 2026.
Not reported for Q1 2026.
Margins & Returns
Quipt Home Medical Corp.'s gross margin was 71.9% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.
Quipt Home Medical Corp.'s operating margin was 1.3% in Q1 2026, reflecting core business profitability. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.4 percentage points.
Quipt Home Medical Corp.'s net profit margin was -1.3% in Q1 2026, showing the share of revenue converted to profit. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.9 percentage points.
Quipt Home Medical Corp.'s ROE was -0.9% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.2 percentage points.
Capital Allocation
Quipt Home Medical Corp. invested $2.1M in capex in Q1 2026, funding long-term assets and infrastructure. This represents a decrease of 43.7% from the same quarter a year earlier. Against the prior quarter it is up 13.7%.
Not reported for Q1 2026.
Not reported for Q1 2026.
QIPT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $81.0M+32.0% | $68.3M+11.4% | $58.3M-4.1% | $57.4M-6.3% | $61.4M-1.9% | $61.3M | $60.8M | $61.3M |
| Cost of Revenue | $22.8M+28.2% | $20.4M+15.5% | $14.9M-10.9% | $15.1M-9.2% | $17.8M-0.7% | $17.7M | $16.7M | $16.7M |
| Gross Profit | $58.2M+33.5% | $47.9M+9.7% | $43.4M-1.5% | $42.2M-5.3% | $43.6M-2.4% | $43.7M | $44.1M | $44.6M |
| SG&A Expenses | $27.3M+37.8% | $21.5M+6.7% | $19.2M-1.6% | $18.8M-5.8% | $19.8M+2.7% | $20.2M | $19.5M | $19.9M |
| Operating Income | $1.0M+128.6% | -$1.4M-50.8% | -$1.8M-1923.0% | -$999K-210.9% | $448K-58.3% | -$961K | $100K | $901K |
| EBITDA | $13.6M+18.7% | $9.9M-0.4% | $9.7M-16.1% | $10.7M-11.1% | $11.4M-6.6% | $9.9M | $11.5M | $12.0M |
| Interest Expense | $1.4M+8.8% | $1.3M-6.6% | $1.2M-6.6% | $1.3M-1.7% | $1.3M-3.8% | $1.4M | $1.3M | $1.3M |
| Income Tax | $25K-16.7% | $141K+137.7% | $35K | $35K-86.7% | $30K-86.4% | -$374K | $0 | $263K |
| Net Income | -$1.1M+2.9% | -$3.5M-20.7% | -$3.0M-89.5% | -$3.0M-311.6% | -$1.1M+27.2% | -$2.9M | -$1.6M | -$739K |
| EPS (Basic) | -$0.02+33.3% | -$0.070.0% | -$0.07-75.0% | -$0.07-250.0% | -$0.03+25.0% | -$0.07 | -$0.04 | -$0.02 |
| EPS (Diluted) | -$0.02+33.3% | -$0.070.0% | -$0.07-75.0% | -$0.07-250.0% | -$0.03+25.0% | -$0.07 | -$0.04 | -$0.02 |
| Diluted Shares (Avg) | 43,609+1.2% | N/A | 43,459+2.0% | 43,170+2.3% | 43,091+2.3% | N/A | 42,623 | 42,185 |
Not reported in any period shown, so not listed: R&D Expenses.
QIPT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $280.7M+15.6% | $283.3M+14.6% | $236.1M | $244.6M | $242.8M | $247.2M-0.1% | N/A | N/A |
| Current Assets | $78.1M+12.1% | $78.3M+7.2% | $68.7M | $75.0M | $69.7M | $73.1M+11.6% | N/A | N/A |
| Cash & Equivalents | $10.5M-31.8% | $12.9M-20.1% | $11.3M-21.9% | $17.1M+17.4% | $15.5M-15.7% | $16.2M-6.0% | $14.4M | $14.6M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $26.9M+34.2% | $25.6M+23.0% | $24.0M | $22.8M | $20.1M | $20.9M+13.2% | N/A | N/A |
| Accounts Receivable | $34.9M+26.3% | $34.7M+19.2% | $27.0M | $29.5M | $27.6M | $29.1M+12.1% | N/A | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $61.6M+21.3% | $61.6M+21.3% | $50.7M | $50.7M | $50.7M | $50.7M-4.0% | N/A | N/A |
| Total Liabilities | $167.7M+22.8% | $171.2M+22.2% | $133.6M | $141.1M | $136.5M | $140.1M-60.9% | N/A | N/A |
| Current Liabilities | $75.2M+31.8% | $74.7M+22.8% | $59.8M | $61.3M | $57.1M | $60.9M+0.5% | N/A | N/A |
| Non-Current Liabilities | $92.4M+16.4% | $96.5M+21.8% | $73.7M | $79.7M | $79.4M | $79.2M-73.4% | N/A | N/A |
| Long-Term Debt | $84.0M+18.9% | $87.6M+15.1% | $66.0M | $71.5M | $70.6M | $76.1M | N/A | N/A |
| Total Equity | $113.0M+6.3% | $112.1M+4.6% | $102.5M-6.6% | $103.6M-6.1% | $106.3M-3.9% | $107.2M+196.5% | $109.8M | $110.3M |
| Retained Earnings | -$182.3M-6.2% | -$181.3M-6.3% | -$177.7M | -$174.7M | -$171.7M | -$170.6M-4.1% | N/A | N/A |
QIPT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.9M-3.9% | $9.8M-2.0% | $9.7M-8.0% | $8.9M+108.6% | $9.3M-12.3% | $10.0M | $10.5M | $4.3M |
| Depreciation & Amortization | $12.6M+14.2% | $11.9M+2.9% | $11.5M+0.6% | $11.7M+5.1% | $11.0M-1.6% | $11.5M | $11.4M | $11.1M |
| Stock-Based Compensation | $982K+374.4% | N/A | $2.1M+338.9% | $298K-57.5% | $207K-78.7% | N/A | $483K | $701K |
| Capital Expenditures | $2.1M-43.7% | $1.8M-47.3% | $5.2M+27.9% | $1.6M+35.9% | $3.7M+134.3% | $3.5M | $4.1M | $1.2M |
| Free Cash Flow | $6.9M+22.2% | $8.0M+22.1% | $4.4M-30.9% | $7.3M+136.3% | $5.6M-37.8% | $6.5M | $6.4M | $3.1M |
| Investing Cash Flow | -$1.9M+46.6% | -$23.3M-593.8% | -$4.4M-6.5% | -$1.6M-31.6% | -$3.6M-123.4% | -$3.4M | -$4.1M | -$1.2M |
| Financing Cash Flow | -$9.4M-70.9% | $15.2M+402.8% | -$11.8M-84.0% | -$5.7M+13.1% | -$5.5M+32.3% | -$5.0M | -$6.4M | -$6.6M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
QIPT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.9%+0.8pp | 70.1%-1.1pp | 74.5%+2.0pp | 73.6%+0.8pp | 71.0%-0.3pp | 71.2% | 72.5% | 72.8% |
| Operating Margin | 1.3%+0.5pp | -2.1%-0.6pp | -3.1%-3.3pp | -1.7%-3.2pp | 0.7%-1.0pp | -1.6% | 0.2% | 1.5% |
| Net Margin | -1.3%+0.5pp | -5.2%-0.4pp | -5.2%-2.6pp | -5.3%-4.1pp | -1.8%+0.6pp | -4.8% | -2.6% | -1.2% |
| Return on Equity | -0.9%+0.1pp | -3.2%-0.4pp | -2.9%-1.5pp | -2.9%-2.3pp | -1.0%+0.3pp | -2.7% | -1.5% | -0.7% |
| Return on Assets | -0.4%+0.1pp | -1.3%-0.1pp | -1.3% | -1.2% | -0.4% | -1.2% | N/A | N/A |
| Current Ratio | 1.04-0.2x | 1.05-0.2x | 1.15 | 1.22 | 1.22 | 1.20+0.1x | N/A | N/A |
| Debt-to-Equity | 0.74+0.1x | 0.78+0.1x | 0.64 | 0.69 | 0.66 | 0.71 | N/A | N/A |
| Asset Turnover | 0.290.0x | 0.240.0x | 0.25 | 0.23 | 0.25 | 0.25 | N/A | N/A |
| FCF Margin | 8.5%-0.7pp | 11.6%+1.0pp | 7.6%-2.9pp | 12.8%+7.7pp | 9.2%-5.3pp | 10.6% | 10.5% | 5.1% |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Quipt Home Medical Corp. QIPT | FY2025 | $245.4M | -$10.7M | -4.4% | $162.3M | 38/100 |
| EDAP TMS SA EDAP | FY2025 | $70.5M | -$29.2M | -41.5% | $161.9M | 33/100 |
| 111, Inc. YI | FY2025 | $1.8B | -$3.2M | -0.2% | $27.7M | 19/100 |
| ZYNEX INC ZYXI | FY2024 | $192.4M | $3.0M | 1.6% | $3.8M | 59/100 |
| Owens & Minor, Inc. OMI | FY2025 | $2.8B | -$1.1B | -39.9% | $216.6M | 22/100 |
| Synergy CHC Corp. SNYR | FY2025 | $30.4M | -$12.3M | -40.6% | $1.3M | 8/100 |
Where Quipt Home Medical Corp. Ranks
Frequently Asked Questions
What is Quipt Home Medical Corp.'s annual revenue?
Quipt Home Medical Corp. (QIPT) reported $245.4M in total revenue for fiscal year 2025. This represents a -0.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Quipt Home Medical Corp.'s revenue growing?
Quipt Home Medical Corp. (QIPT) revenue declined by 0.2% year-over-year, from $245.9M to $245.4M in fiscal year 2025.
Is Quipt Home Medical Corp. profitable?
No, Quipt Home Medical Corp. (QIPT) reported a net income of -$10.7M in fiscal year 2025, with a net profit margin of -4.4%.
What is Quipt Home Medical Corp.'s EBITDA?
Quipt Home Medical Corp. (QIPT) had EBITDA of $41.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Quipt Home Medical Corp. have?
As of fiscal year 2025, Quipt Home Medical Corp. (QIPT) had $12.9M in cash and equivalents against $87.6M in long-term debt.
What is Quipt Home Medical Corp.'s gross margin?
Quipt Home Medical Corp. (QIPT) had a gross margin of 72.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Quipt Home Medical Corp.'s operating margin?
Quipt Home Medical Corp. (QIPT) had an operating margin of -1.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Quipt Home Medical Corp.'s net profit margin?
Quipt Home Medical Corp. (QIPT) had a net profit margin of -4.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Quipt Home Medical Corp.'s return on equity (ROE)?
Quipt Home Medical Corp. (QIPT) has a return on equity of -9.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Quipt Home Medical Corp.'s free cash flow?
Quipt Home Medical Corp. (QIPT) generated $25.3M in free cash flow during fiscal year 2025. This represents a 1.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Quipt Home Medical Corp.'s operating cash flow?
Quipt Home Medical Corp. (QIPT) generated $37.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Quipt Home Medical Corp.'s total assets?
Quipt Home Medical Corp. (QIPT) had $283.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Quipt Home Medical Corp.'s capital expenditures?
Quipt Home Medical Corp. (QIPT) invested $12.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Quipt Home Medical Corp.'s current ratio?
Quipt Home Medical Corp. (QIPT) had a current ratio of 1.05 as of fiscal year 2025, which is considered adequate.
What is Quipt Home Medical Corp.'s debt-to-equity ratio?
Quipt Home Medical Corp. (QIPT) had a debt-to-equity ratio of 0.78 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Quipt Home Medical Corp.'s return on assets (ROA)?
Quipt Home Medical Corp. (QIPT) had a return on assets of -3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Quipt Home Medical Corp.'s Altman Z-Score?
Quipt Home Medical Corp. (QIPT) has an Altman Z-Score of 0.51, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Quipt Home Medical Corp.'s Piotroski F-Score?
Quipt Home Medical Corp. (QIPT) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Quipt Home Medical Corp.'s earnings high quality?
Quipt Home Medical Corp. (QIPT) reported a net loss of $10.7M while generating $37.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Quipt Home Medical Corp. cover its interest payments?
Quipt Home Medical Corp. (QIPT) reported an operating loss of $3.8M against $5.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Quipt Home Medical Corp.?
Quipt Home Medical Corp. (QIPT) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.